Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 8, 2018
Emerging therapies for haemophilia - Global perspectiveJ Mahlangu, M Cerquiera, A Srivastava
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 9, 2016
TRUST trial: BAY 86-6150 use in haemophilia with inhibitors and assessment for immunogenicityJ Mahlangu, P Paz, M Hardtke, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 11, 2018
Defining extended half-life rFVIII-A critical review of the evidenceJ Mahlangu, G Young, C Hermans, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|June 1, 2001
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and multiple myeloma in South AfricaM Patel, J Mahlangu, J Patel, et al.
Journal of Virological Methods|May 24, 2011
Palindromic-nucleotide substitutions (PNS) of hepatitis C virus genotypes 1 and 5a from South AfricaN Prabdial-Sing, M Giangaspero, A J Puren, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2011
Haemophilia management: time to get personal?T E Howard, C Yanover, J Mahlangu, et al.
Antiviral Research|December 26, 2015
Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South AfricaN Prabdial-Sing, J T Blackard, A J Puren, et al.
Cytokine|February 5, 2020
Elevated T-helper 2 cytokine levels in high fat diet-fed C57BL/6 mice are attenuated by short-term 6-week treatment with a combination of low-dose aspirin and metforminThabsile J Mahlangu, Phiwayinkosi V Dludla, Vuyolwethu Mxinwa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 8, 2018
Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIIIC Hermans, J Mahlangu, J Booth, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 8, 2016
Changes in health-related quality of life with treatment of longer-acting clotting factors: results in the A-LONG and B-LONG clinical studiesK W Wyrwich, S Krishnan, P Auguste, et al.
Pageof 2